Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Oral zinc sulphate reduces dark hair color in mice.

Dutasteride may protect the brain in early Parkinson's disease.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.